Snack-sized quantities of walnuts slow cancer growth in mice, reports a Marshall University pilot study published in the current issue of the peer-reviewed journal Nutrition and Cancer.
Researcher W. Elaine Hardman, Ph.D., of Marshall’s Joan C. Edwards School [...]

Boston Scientific Corporation (NYSE: BSX) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Express2(TM) Atom(TM) Paclitaxel-Eluting Coronary Stent System. The TAXUS Express Atom Stent is a highly deliverable drug-eluting stent (DES) specifically designed for treating small coronary vessels. It [...]

While there are many causes of advanced liver disease, fatty liver, or NASH (nonalcoholic steatohepatitis), has become the second leading cause of liver transplant in the United States. Obesity, along with elevated cholesterol and diabetes, has long been known to cause increased fat stores, which may be injurious to the [...]

DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its Guanylyl Cyclase C (GCC) marker for identifying colorectal cancer cells is being featured at two scientific meetings this [...]

“Little strokes, big trouble,” is the theme of this year’s World Stroke Day on October 29th. Subclinical strokes, which are a risk factor for strokes and dementia, are very common and affect every tenth apparently healthy middle-aged person. The WSO World Stroke Day Proclamation aims to improve global awareness of the “preventable catastrophe” stroke represents. [...]